Matches in SemOpenAlex for { <https://semopenalex.org/work/W2367721579> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2367721579 abstract "Objective: To retrospectively analyze the effects of corticosteroids with mycophenolate mofetil( MMF)treatment on long-term outcome in ANCA associated vasculitis( AAV) patients with renal involvement. Methodology:Fifty one AAV patients with renal involvement( male 21,female 30,average age 46. 4 ± 15. 8 years) from January 2000 to June 2012 were enrolled in the study,The baseline median BVAS score was 13 and serum creatinine( SCr) was 203. 3 ±106. 1 μmol / L. All patients received corticosteroids in combined with MMF( 1 ~ 2. 0 g / d) for induction therapy,among them 14 patients received immunoadsorption( n = 11) or double filtration plasmapheresis additionally( n = 3),after remission corticosteroids in combined with MMF was given continue for maintenance therapy. The clinical effects,patient and renal survival of corticosteroids with MMF in AAV with renal involvement were investigated. Results: The patients were treated with MMF for 3 ~ 120 months( median of 23 months) and had a follow-up time from 3 to 155 months( median of 56 months). In the induction stage with MMF,46( 90. 2%) patients achieved remission and went into the maintenance therapy,one died because of pulmonary infection,one developed to end stage renal disease( ESRD),and 3 patients had no response to the therapy. During the follow-up,3 patients died of pulmonary infection,the cumulative patient survival at3 and 5 year was both 93. 2%,and 7 patients developed to ESRD,the cumulative renal survival at 3 and 5year was 91. 8%and 83. 0%. 13 cases( 28. 3%) relapsed,the median relapse time was 43 months,accumulated relapse rate at 3 and 5year was 13. 2% and 25. 6%. A total of 29 adverse reactions occurred in 21( 41. 2%) patients,including infection( n =27) and hyperglycemia( n = 2),among them 16 were pulmonary infection. Conclusion: Corticosteroids with MMF was effective for treating AAV with renal involvement,while pulmonary infection was the common complication and cause of death. Further large-scale multicentre randomized controlled trials will be needed to confirm these findings." @default.
- W2367721579 created "2016-06-24" @default.
- W2367721579 creator A5060089075 @default.
- W2367721579 date "2014-01-01" @default.
- W2367721579 modified "2023-09-24" @default.
- W2367721579 title "Corticosteroids combined with mycophenolate mofetil treatment on long-term outcome in anti-neutrophil cytoplasmic antibodies associated vasculitis with renal involvement" @default.
- W2367721579 hasPublicationYear "2014" @default.
- W2367721579 type Work @default.
- W2367721579 sameAs 2367721579 @default.
- W2367721579 citedByCount "0" @default.
- W2367721579 crossrefType "journal-article" @default.
- W2367721579 hasAuthorship W2367721579A5060089075 @default.
- W2367721579 hasConcept C126322002 @default.
- W2367721579 hasConcept C141071460 @default.
- W2367721579 hasConcept C159641895 @default.
- W2367721579 hasConcept C159654299 @default.
- W2367721579 hasConcept C203014093 @default.
- W2367721579 hasConcept C2776015282 @default.
- W2367721579 hasConcept C2778842783 @default.
- W2367721579 hasConcept C2779134260 @default.
- W2367721579 hasConcept C2780306776 @default.
- W2367721579 hasConcept C2909935303 @default.
- W2367721579 hasConcept C2911091166 @default.
- W2367721579 hasConcept C3019040382 @default.
- W2367721579 hasConcept C71924100 @default.
- W2367721579 hasConcept C90924648 @default.
- W2367721579 hasConceptScore W2367721579C126322002 @default.
- W2367721579 hasConceptScore W2367721579C141071460 @default.
- W2367721579 hasConceptScore W2367721579C159641895 @default.
- W2367721579 hasConceptScore W2367721579C159654299 @default.
- W2367721579 hasConceptScore W2367721579C203014093 @default.
- W2367721579 hasConceptScore W2367721579C2776015282 @default.
- W2367721579 hasConceptScore W2367721579C2778842783 @default.
- W2367721579 hasConceptScore W2367721579C2779134260 @default.
- W2367721579 hasConceptScore W2367721579C2780306776 @default.
- W2367721579 hasConceptScore W2367721579C2909935303 @default.
- W2367721579 hasConceptScore W2367721579C2911091166 @default.
- W2367721579 hasConceptScore W2367721579C3019040382 @default.
- W2367721579 hasConceptScore W2367721579C71924100 @default.
- W2367721579 hasConceptScore W2367721579C90924648 @default.
- W2367721579 hasLocation W23677215791 @default.
- W2367721579 hasOpenAccess W2367721579 @default.
- W2367721579 hasPrimaryLocation W23677215791 @default.
- W2367721579 hasRelatedWork W1511911200 @default.
- W2367721579 hasRelatedWork W1966721955 @default.
- W2367721579 hasRelatedWork W1972054849 @default.
- W2367721579 hasRelatedWork W1977743910 @default.
- W2367721579 hasRelatedWork W2008125990 @default.
- W2367721579 hasRelatedWork W2013655573 @default.
- W2367721579 hasRelatedWork W2054114584 @default.
- W2367721579 hasRelatedWork W2064342954 @default.
- W2367721579 hasRelatedWork W2113281485 @default.
- W2367721579 hasRelatedWork W2365688098 @default.
- W2367721579 hasRelatedWork W2380119981 @default.
- W2367721579 hasRelatedWork W2401526186 @default.
- W2367721579 hasRelatedWork W2481125963 @default.
- W2367721579 hasRelatedWork W2554264138 @default.
- W2367721579 hasRelatedWork W2783084540 @default.
- W2367721579 hasRelatedWork W2906629149 @default.
- W2367721579 hasRelatedWork W2983359516 @default.
- W2367721579 hasRelatedWork W3000657799 @default.
- W2367721579 hasRelatedWork W3093610375 @default.
- W2367721579 hasRelatedWork W3146880376 @default.
- W2367721579 isParatext "false" @default.
- W2367721579 isRetracted "false" @default.
- W2367721579 magId "2367721579" @default.
- W2367721579 workType "article" @default.